Psychiatry

Back to articles

Prolonged-release melatonin effective for sleep disturbances in children with neurodevelopmental disabilities

KEY POINT

Use of prolonged-release melatonin for children with autism spectrum disorder and sleep disturbances, with or without attention-deficit/hyperactivity disorder, resulted in a longer sleep duration and shorter sleep latency compared with placebo according to results of a trial published in the Journal of the American Academy of Child and Adolescent Psychiatry.

SOURCES

Gringras P, et al. Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2017;56(11):946–57. http://dx.doi.org/10.1016/j.jaac.2017.09.414